Insomnia Therapeutics Market Report

Insomnia Therapeutics Market Analysis By Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], By Sales Channel, And Segment Forecasts, 2018 - 2025

  • Published Date: Oct, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-2-68038-213-6
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 101

Market Segmentation

  • Insomnia therapeutics market Product Outlook (Revenue, USD Million, 2014 - 2025)
    • Drugs
      • Benzodiazepines
      • Nonbenzodiazepines
      • Antidepressants
      • Orexin antagonists
      • Melatonin antagonists
      • Others
    • Devices
  • Insomnia Therapeutics Market Sales channel Outlook (Revenue, USD Million, 2014 - 2025)
    • Prescription
    • Over-the-Counter (OTC)
  • Insomnia Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • North America Insomnia Therapeutics Market, By Treatment type
        • Drugs
          • Benzodiazepines
          • Nonbenzodiazepines
          • Antidepressants
          • Orexin antagonists
          • Melatonin antagonists
          • Others
        • Devices
      • North America Insomnia Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • The U.S.
        • U.S. Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • U.S. Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Canada
        • Canada Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • Canada Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • Europe
      • Europe Insomnia Therapeutics Market, By Treatment type
        • Drugs
          • Benzodiazepines
          • Nonbenzodiazepines
          • Antidepressants
          • Orexin antagonists
          • Melatonin antagonists
          • Others
        • Devices
      • Europe Insomnia Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • The U.K.
        • U.K. Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • U.K. Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Germany
        • Germany Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • Germany Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • Asia Pacific
      • Asia Pacific Insomnia Therapeutics Market, By Treatment type
        • Drugs
          • Benzodiazepines
          • Nonbenzodiazepines
          • Antidepressants
          • Orexin antagonists
          • Melatonin antagonists
          • Others
        • Devices
      • Asia Pacific Insomnia Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • Japan
        • Japan Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • Japan Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • China
        • China Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • China Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • Latin America
      • Latin America Insomnia Therapeutics Market, By Treatment type
        • Drugs
          • Benzodiazepines
          • Nonbenzodiazepines
          • Antidepressants
          • Orexin antagonists
          • Melatonin antagonists
          • Others
        • Devices
      • Latin America Insomnia Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • Mexico
        • Mexico Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • Mexico Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Brazil
        • Brazil Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • Brazil Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • MEA
      • MEA Insomnia Therapeutics Market, By Treatment type
        • Drugs
          • Benzodiazepines
          • Nonbenzodiazepines
          • Antidepressants
          • Orexin antagonists
          • Melatonin antagonists
          • Others
        • Devices
      • MEA Insomnia Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • South Africa
        • South Africa. Insomnia Therapeutics Market, By Treatment type
          • Drugs
            • Benzodiazepines
            • Nonbenzodiazepines
            • Antidepressants
            • Orexin antagonists
            • Melatonin antagonists
            • Others
          • Devices
        • South Africa Insomnia Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.